The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC—Evaluating the homologous recombination deficiency (HRD) biomarker.
 
Erica L. Mayer
Consulting or Advisory Role - Context Therapeutics; Eisai; Lilly; Novartis; Pfizer
Research Funding - Myriad Genetics (Inst); Pfizer (Inst)
 
Vandana Gupta Abramson
Consulting or Advisory Role - Eisai; Novartis
Research Funding - Astellas Pharma; Genentech/Roche; Lilly
 
Rachel Catherine Jankowitz
Honoraria - Eisai
 
Carla Isadora Falkson
Honoraria - Agendia; Biotheranostics; Cardinal Health
Consulting or Advisory Role - Biotheranostics; Cardinal Health
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
Travel, Accommodations, Expenses - Agendia; Biotheranostics; Cardinal Health
 
Paul Kelly Marcom
Consulting or Advisory Role - Celltrion; Genentech/Roche; Immunomedics; Merck
Speakers' Bureau - Catamount Medical Education; Clinical Care Options
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Innocrin Pharma (Inst); Novartis (Inst); Veridex (Inst); Verily (Inst)
 
Tiffany A. Traina
Consulting or Advisory Role - Aduro Biotech; Advaxis; Astellas Pharma; AstraZeneca; Athenex; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Halozyme; Halozyme; Halozyme; Halozyme; Halozyme; Innocrin Pharma; Medivation; Merck; Pfizer; Puma Biotechnology; Samsung
Speakers' Bureau - Roche/Genentech
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Lisa A. Carey
Research Funding - Immunomedics (Inst); Innocrin Pharma (Inst); Syndax (Inst)
Patents, Royalties, Other Intellectual Property - Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme. (I)
 
Mothaffar F. Rimawi
Consulting or Advisory Role - Daiichi Sankyo; Genentech; Macrogenics; Novartis
Research Funding - Pfizer (Inst)
 
Jennifer M. Specht
Consulting or Advisory Role - Abbvie; Advaxis; Celgene; Genomic Health; Nektar
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Celgene (Inst); Celldex (Inst); Genentech/Roche (Inst); Juno Therapeutics (Inst); Merck (Inst); Myriad Pharmaceuticals (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Nektar
 
Kathy Miller
Consulting or Advisory Role - Merck; Nektar; Tesaro
Research Funding - EntreMed (Inst); Genentech (Inst); Macrogenics (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Vered Stearns
Consulting or Advisory Role - Iridium Therapeutics
Research Funding - Abbvie; Biocept; MedImmune; Novartis; Pfizer; Puma Biotechnology
Other Relationship - Immunomedics
 
Charles M. Perou
Leadership - Bioclassifier; GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric
Consulting or Advisory Role - Bioclassifier; G1 Therapeutics; GeneCentric; Ions Pharmaceuticals
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent
Travel, Accommodations, Expenses - Chugai Pharma; Takeda
 
Andrea L. Richardson
Honoraria - OncLive
Consulting or Advisory Role - Genomic Health
Patents, Royalties, Other Intellectual Property - Inventor on HRD assay licensed to Myriad genetics. The IP is designated to Partners Healthcare. I am entitled to royalties and license fees.
 
Nadine M. Tung
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
William Thomas Barry
Research Funding - Pfizer (Inst)
Other Relationship - ARMO BioSciences
 
Zhenying Tan-Wasielewski
No Relationships to Disclose
 
Kirsten Timms
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Inventor on numerous patents
Travel, Accommodations, Expenses - Myriad Genetics
 
Anne-Renee Hartman
Employment - GRAIL; Myriad Genetics
Stock and Other Ownership Interests - GRAIL; Myriad Genetics
 
Antonio C. Wolff
Research Funding - Biomarin (Inst); Celldex (Inst); Myriad Genetics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Eric P. Winer
Stock and Other Ownership Interests - Verastem
Honoraria - Carrick Therapeutics; Genentech/Roche; GlaxoSmithKline; InfiniteMD; Jounce Therapeutics; Jounce Therapeutics; Lilly; Tesaro
Consulting or Advisory Role - InfiniteMD; Leap Therapeutics
Research Funding - Genentech (Inst)